Lyell Immunopharma (LYEL) Other Non-Current Assets (2020 - 2026)
Lyell Immunopharma's Other Non-Current Assets was $5.84 million in Q2 2026, up 268.8% from $1.58 million a year earlier and up 11.6% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Other Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Assets at Lyell Immunopharma came in at $4.89 million, up 5.7% from FY2024.
- Other Non-Current Assets shows a five-year compound annual growth rate of 60.0% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $4.62 million in FY2024, $284,000 in FY2023 (+1.4%), $280,000 in FY2022 (-39.9%) and $466,000 in FY2021 (unchanged).
- The Q2 2026 figure marks the highest quarterly Other Non-Current Assets in data going back to Q2 2020.
- Compared with a year earlier, Other Non-Current Assets has increased for six straight quarters, with growth averaging 316.0% over the last seven quarters.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q3 2025 (growth of 783.7%); the worst was Q1 2022 (a decline of 40.1%).
- Per Business Quant data, LYEL's Other Non-Current Assets in the three quarters before Q2 2026 was $5.23 million (Q1 2026), $4.89 million (Q4 2025) and $2.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Lyell Immunopharma | 229.06 Mn | 229.06 Mn | - | 5.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.84 Mn |
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 4.89 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 288,000.00 |
| Jun 30, 2024 | 287,000.00 |
| Mar 31, 2024 | 286,000.00 |
| Dec 31, 2023 | 284,000.00 |
| Sep 30, 2023 | 283,000.00 |
| Jun 30, 2023 | 282,000.00 |
| Mar 31, 2023 | 281,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Sep 30, 2022 | 279,000.00 |
| Jun 30, 2022 | 279,000.00 |
| Mar 31, 2022 | 279,000.00 |
| Dec 31, 2021 | 466,000.00 |
| Sep 30, 2021 | 466,000.00 |
API Access
Lyell Immunopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();